{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:54:56Z","timestamp":1781643296726,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitral stenosis (MS) causes chronic pressure overload and secondary pulmonary hypertension, which are associated with activation of hypoxia-inducible pathways. This study investigated the circulating levels of hypoxia-inducible factor-2\u03b1 (Endothelial PAS domain protein 1-EPAS1) in patients with MS and their relationship with disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study included 69 patients diagnosed with rheumatic MS and an equal number of age- and sex-matched healthy individuals. Hypoxia-inducible factor-2\u03b1 (HIF-2\u03b1) levels were assessed using an enzyme-linked immunosorbent assay (ELISA) along with conventional biomarkers, and all patients underwent echocardiographic assessments. Statistical comparisons were performed using appropriate parametric or non-parametric tests, and relationships were evaluated using Spearman\u2019s rank correlation coefficients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HIF-2\u03b1 levels were significantly higher in patients with MS than in the controls (median 5.2 vs. 4.7;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0275). Patients with MS also had higher high-sensitivity cardiac troponin T levels (median 7.7 vs. 4.9,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0328) than controls. HIF-2\u03b1 was weakly positively correlated with systolic pulmonary artery pressure (\u03c1\u2009=\u20090.28,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), left atrial diameter (\u03c1\u2009=\u20090.22,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012), and N-terminal pro-B-type natriuretic peptide level (\u03c1\u2009=\u20090.29,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014). HIF-2\u03b1 levels did not significantly correlate with the mitral valve area or mean transmitral gradient.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated HIF-2\u03b1 levels in patients with MS are correlated with pulmonary hypertension and cardiac stress. These findings support the involvement of hypoxia-inducible pathways in the pathophysiology of MS. However, HIF-2\u03b1 elevation is modest and its clinical utility as a biomarker for MS is currently limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-026-05744-6","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:25:04Z","timestamp":1773671104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitral stenosis severity and the hypoxic response: potential role of hypoxia-inducible factor-2\u03b1 - a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Meltem","family":"Uyaner Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-4592","authenticated-orcid":false,"given":"Hasan","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Alsancak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Alkan Baylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"5744_CR1","doi-asserted-by":"publisher","first-page":"147376","DOI":"10.1016\/j.gene.2023.147376","volume":"868","author":"M Ja\u015bkiewicz","year":"2023","unstructured":"Ja\u015bkiewicz M, Moszy\u0144ska A, Gebert M, Collawn JF, Bartoszewski R. EPAS1 resistance to miRNA-based regulation contributes to prolonged expression of HIF-2 during hypoxia in human endothelial cells. Gene. 2023;868:147376\u2013147376.","journal-title":"Gene"},{"key":"5744_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1152\/physiol.00018.2018","volume":"33","author":"G Marsboom","year":"2018","unstructured":"Marsboom G, Rehman J. Hypoxia signaling in vascular homeostasis. Physiology. 2018;33:328\u201337.","journal-title":"Physiology"},{"key":"5744_CR3","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1172\/JCI137558","volume":"130","author":"SS Pullamsetti","year":"2020","unstructured":"Pullamsetti SS, Mamazhakypov A, Weissmann N, Seeger W, Savai R. Hypoxia-inducible factor signaling in pulmonary hypertension. J Clin Invest. 2020;130:5638\u201351.","journal-title":"J Clin Invest"},{"key":"5744_CR4","doi-asserted-by":"publisher","first-page":"H14","DOI":"10.1152\/ajpheart.00720.2016","volume":"313","author":"K Salhiyyah","year":"2017","unstructured":"Salhiyyah K, Sarathchandra P, Latif N, Yacoub MH, Chester AH. Hypoxia-mediated regulation of the secretory properties of mitral valve interstitial cells. Am J Physiol - Hear Circ Physiol. 2017;313:H14\u201323.","journal-title":"Am J Physiol - Hear Circ Physiol"},{"key":"5744_CR5","first-page":"558","volume":"23","author":"H Akahori","year":"2014","unstructured":"Akahori H, Tsujino T, Naito Y, Sawada H, Sugahara M, Fukui M, Ohyanagi M, Mitsuno M, Miyamoto Y, Masuyama T. Nuclear factor-\u03baB-hypoxia-inducible factor-2 pathway in aortic valve stenosis. J Heart Valve Dis. 2014;23:558\u201366.","journal-title":"J Heart Valve Dis"},{"key":"5744_CR6","doi-asserted-by":"publisher","first-page":"1125723","DOI":"10.3389\/fcell.2023.1125723","volume":"11","author":"N Wang","year":"2023","unstructured":"Wang N, Hua J, Fu Y, An J, Chen X, Wang C, Zheng Y, Wang F, Ji Y, Li Q. Updated perspective of EPAS1 and the role in pulmonary hypertension. Front Cell Dev Biol. 2023;11:1125723.","journal-title":"Front Cell Dev Biol"},{"key":"5744_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.echo.2022.10.009","volume":"36","author":"NG Pandian","year":"2023","unstructured":"Pandian NG, Kim JK, Arias-Godinez JA, et al. Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36:3\u201328.","journal-title":"J Am Soc Echocardiogr"},{"key":"5744_CR8","doi-asserted-by":"publisher","first-page":"447461","DOI":"10.3389\/fmed.2019.00093","volume":"6","author":"JM Young","year":"2019","unstructured":"Young JM, Williams DR, Thompson AAR. Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension. Front Med. 2019;6:447461.","journal-title":"Front Med"},{"key":"5744_CR9","first-page":"L256","volume":"314","author":"H Tang","year":"2018","unstructured":"Tang H, Babicheva A, McDermott KM, et al. Endothelial HIF-2\u03b1 contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am J Physiol - Lung Cell Mol Physiol. 2018;314:L256\u201375.","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"5744_CR10","first-page":"1","volume":"51","author":"JW Lee","year":"2019","unstructured":"Lee JW, Ko J, Ju C, Eltzschig HK. Hypoxia signaling in human diseases and therapeutic targets. Exp Mol Med. 2019;51:1\u201313.","journal-title":"Exp Mol Med"},{"key":"5744_CR11","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/ATVBAHA.117.310149","volume":"37","author":"X Li","year":"2017","unstructured":"Li X, Weintraub DS, Fulton DJR. Beyond impressions how altered shear stress connects hypoxic signaling to endothelial inflammation. Arterioscler Thromb Vasc Biol. 2017;37:1987\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5744_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.bbadis.2016.01.017","volume":"1862","author":"B Stavik","year":"2016","unstructured":"Stavik B, Espada S, Cui XY, Iversen N, Holm S, Mowinkel MC, Halvorsen B, Skretting G, Sandset PM. EPAS1\/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells. Biochim Biophys Acta - Mol Basis Dis. 2016;1862:670\u20138.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"5744_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/AC.67.1.2146566","volume":"67","author":"\u00d6 U\u00e7ar","year":"2012","unstructured":"U\u00e7ar \u00d6, Bayar N, Karag\u00f6z A, Aydogdu S. Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis. Acta Cardiol. 2012;67:59\u201364.","journal-title":"Acta Cardiol"},{"key":"5744_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-020-01435-y","volume":"20","author":"M Badoz","year":"2020","unstructured":"Badoz M, Arrigo M, Mogenet AC, Sadoune M, Meneveau N, Mebazaa A, Seronde MF. Assessment of successful percutaneous mitral commissurotomy by MRproANP and sCD146. BMC Cardiovasc Disord. 2020;20:1\u20139.","journal-title":"BMC Cardiovasc Disord"},{"key":"5744_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/0971-9784.179638","volume":"19","author":"A Martin","year":"2016","unstructured":"Martin A, Malhotra A, Sullivan B, Ramakrishna H. Troponin elevations in patients with chronic cardiovascular disease: An analysis of current evidence and significance. Ann Card Anaesth. 2016;19:321\u20137.","journal-title":"Ann Card Anaesth"},{"key":"5744_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.119.012156","volume":"8","author":"K Charitakis","year":"2019","unstructured":"Charitakis K, Nguyen TC. Severe Symptomatic Aortic Stenosis? Check Troponin, Too. J Am Heart Assoc. 2019;8:1\u20132.","journal-title":"J Am Heart Assoc"},{"key":"5744_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41569-023-00886-y","volume":"20","author":"Y Liang","year":"2023","unstructured":"Liang Y, Ruan W, Jiang Y, Smalling R, Yuan X, Eltzschig HK. Interplay of hypoxia-inducible factors and oxygen therapy in cardiovascular medicine. Nat Rev Cardiol. 2023;20:723\u201337.","journal-title":"Nat Rev Cardiol"},{"key":"5744_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/cells14090673","volume":"14","author":"MZ Bakleh","year":"2025","unstructured":"Bakleh MZ, Al Haj Zen A. The Distinct Role of HIF-1\u03b1 and HIF-2\u03b1 in Hypoxia and Angiogenesis. Cells. 2025;14:673.","journal-title":"Cells"},{"key":"5744_CR19","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"C-J Hu","year":"2003","unstructured":"Hu C-J, Wang L-Y, Chodosh LA, Keith B, Simon MC. Differential Roles of Hypoxia-Inducible Factor 1\u03b1 (HIF-1\u03b1) and HIF-2\u03b1 in Hypoxic Gene Regulation. Mol Cell Biol. 2003;23:9361\u201374.","journal-title":"Mol Cell Biol"},{"key":"5744_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.it.2016.04.004","volume":"37","author":"D Ferrari","year":"2016","unstructured":"Ferrari D, McNamee EN, Idzko M, Gambari R, Eltzschig HK. Purinergic Signaling During Immune Cell Trafficking. Trends Immunol. 2016;37:399\u2013411.","journal-title":"Trends Immunol"},{"key":"5744_CR21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1089\/ars.2010.3665","volume":"15","author":"A Grenz","year":"2011","unstructured":"Grenz A, Homann D, Eltzschig HK. Extracellular Adenosine: A Safety Signal That Dampens Hypoxia-Induced Inflammation During Ischemia. Antioxid Redox Signal. 2011;15:2221.","journal-title":"Antioxid Redox Signal"},{"key":"5744_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/ALN.0000000000000969","volume":"124","author":"V Neudecker","year":"2016","unstructured":"Neudecker V, Brodsky KS, Kreth S, Ginde AA, Eltzschig HK. Emerging Roles for MicroRNAs in Perioperative Medicine. Anesthesiology. 2016;124:489\u2013506.","journal-title":"Anesthesiology"},{"key":"5744_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/HYPERTENSIONAHA.121.16949","volume":"78","author":"S Wang","year":"2021","unstructured":"Wang S, Wang Y, Liu C, et al. EPAS1 (Endothelial PAS Domain Protein 1) Orchestrates Transactivation of Endothelial ICAM1 (Intercellular Adhesion Molecule 1) by Small Nucleolar RNA Host Gene 5 (SNHG5) to Promote Hypoxic Pulmonary Hypertension. Hypertension. 2021;78:1080\u201391.","journal-title":"Hypertension"},{"key":"5744_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat Rev Drug Discov. 2024;23:175\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"5744_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1213\/ANE.0000000000002288","volume":"126","author":"X Yuan","year":"2018","unstructured":"Yuan X, Lee JW, Bowser JL, Neudecker V, Sridhar S, Eltzschig HK. Targeting Hypoxia Signaling for Perioperative Organ Injury. Anesth Analg. 2018;126:308\u201321.","journal-title":"Anesth Analg"},{"key":"5744_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1164\/rccm.201710-2079OC","volume":"198","author":"Z Dai","year":"2018","unstructured":"Dai Z, Zhu MM, Peng Y, Machireddy N, Evans CE, Machado R, Zhang X, Zhao YY. Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2a inhibitor. Am J Respir Crit Care Med. 2018;198:1423\u201334.","journal-title":"Am J Respir Crit Care Med"},{"key":"5744_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/ham.2024.0119","volume":"26","author":"Y Droma","year":"2025","unstructured":"Droma Y, Ota M, Kobayashi N, Ito M, Kobayashi T, Hanaoka M. Genetic Associations with the Susceptibility to High-Altitude Pulmonary Edema in the Japanese Population. High Alt Med Biol. 2025;26:215\u201326.","journal-title":"High Alt Med Biol"},{"key":"5744_CR28","doi-asserted-by":"publisher","first-page":"e50566","DOI":"10.1371\/journal.pone.0050566","volume":"7","author":"M Hanaoka","year":"2012","unstructured":"Hanaoka M, Droma Y, Basnyat B, Ito M, Kobayashi N, Katsuyama Y, Kubo K, Ota M. Genetic Variants in EPAS1 Contribute to Adaptation to High-Altitude Hypoxia in Sherpas. PLoS ONE. 2012;7:e50566.","journal-title":"PLoS ONE"},{"key":"5744_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41586-025-08898-z","volume":"641","author":"W Ruan","year":"2025","unstructured":"Ruan W, Li T, Bang IH, et al. BMAL1\u2013HIF2A heterodimer modulates circadian variations of myocardial injury. Nature. 2025;641:1017\u201328.","journal-title":"Nature"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05744-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05744-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05744-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:12:21Z","timestamp":1781640741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05744-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5744"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05744-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent prior to participation, and the study protocol was approved by the Necmettin Erbakan University Ethics Committee (approval number: 2025\/5741), in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}